Anti-Inflammatory and Cytoprotective Effects of TMC-256C1 from Marine-Derived Fungus Aspergillus sp. SF-6354 via up-Regulation of Heme Oxygenase-1 in Murine Hippocampal and Microglial Cell Lines

Dongcheol Kim, Kwang Ho Cho, Wonmin Ko, Chi‐Su Yoon, Jae Ho Sohn, Joung Han Yim, Youn‐Chul Kim, Hyuncheol OhInternational Journal of Molecular Sciences 2016 · DOI

TL;DR

Researchers have identified a novel compound, TMC-256C1, from a marine fungus that shows promise in protecting brain cells from damage and reducing inflammation. This compound works by boosting a key cellular defense mechanism, heme oxygenase-1 (HO-1), which is crucial for combating oxidative stress and inflammation in the brain.

What Problem Does This Paper Address?

Neurodegenerative diseases like Alzheimer's and Parkinson's are often characterized by two major pathological processes: oxidative stress and neuroinflammation. Oxidative stress, an imbalance between reactive oxygen species (ROS) and the body's ability to detoxify them, can lead to neuronal injury and death. Neuroinflammation, the inflammatory response within the brain, also contributes significantly to neuronal damage. Microglia, the brain's resident immune cells, play a central role in neuroinflammation; when activated, they release pro-inflammatory mediators that can exacerbate neuronal damage. Current treatments for these conditions are limited, highlighting the need for new therapeutic strategies. This paper investigates a compound from a marine fungus for its potential to address both oxidative stress and neuroinflammation in the brain.

Methods

The study employed a multi-pronged approach to investigate the effects of TMC-256C1:

  • Compound Isolation and Identification: TMC-256C1 was isolated from the marine fungus Aspergillus sp. SF-6354 using chromatographic techniques (flash column chromatography and HPLC). Its structure was confirmed using NMR and MS.
  • Cell Culture Models: Two key cell lines were used:
  • HT22 cells: A mouse hippocampal cell line, commonly used to study glutamate-induced neurotoxicity and oxidative stress.
  • BV2 cells: A microglial cell line, used to model neuroinflammation.
  • Cytotoxicity Assay (MTT): To ensure the compound's effects were not due to cell death, an MTT assay was performed to assess cell viability at various concentrations of TMC-256C1.
  • Oxidative Stress Assays:
    • Glutamate-induced neurotoxicity: HT22 cells were exposed to glutamate (a known neurotoxin) to induce cell death and ROS production. The protective effects of TMC-256C1 were then evaluated.
  • ROS measurement: A fluorescence-based assay was used to quantify ROS generation in glutamate-treated HT22 cells.
  • Inflammation Assays:
    • LPS-induced inflammation: BV2 cells were stimulated with lipopolysaccharide (LPS), a common inducer of inflammation, to mimic an inflammatory response.
  • Cytokine mRNA expression: Quantitative reverse-transcription polymerase chain reaction (RT-qPCR) was used to measure the mRNA levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-12).
  • Nitric Oxide (NO) and Prostaglandin E2 (PGE2) production: Assays were performed to measure the levels of these key inflammatory mediators.
  • Protein expression of iNOS and COX-2: Western blot analysis was used to assess the protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), enzymes involved in NO and PGE2 production, respectively.
  • NF-κB activation: Western blot analysis was used to examine the phosphorylation and degradation of IκB-α, as well as the nuclear translocation of NF-κB subunits (p65 and p50). DNA-binding activity of NF-κB was also assessed.
  • Heme Oxygenase-1 (HO-1) Expression: Western blot analysis was used to measure HO-1 protein levels in both cell types after TMC-256C1 treatment.
  • Nrf2 Nuclear Translocation: Western blot analysis was performed on nuclear and cytoplasmic fractions to assess the translocation of Nrf2, a key transcription factor for HO-1. The role of Nrf2 was further investigated using siRNA.
  • MAPK and PI3K/Akt Pathway Analysis: Western blot analysis was used to examine the phosphorylation of key signaling molecules in the p38 MAPK, JNK, ERK, and PI3K/Akt pathways. The involvement of these pathways was confirmed using specific inhibitors.
  • HO-1 Inhibition Studies: The role of HO-1 was further confirmed by using tin protoporphyrin IX (SnPP), a known HO-1 inhibitor, to see if it reversed the protective effects of TMC-256C1.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Marine Fungi as a Source of Therapeutics: This study reinforces the idea that marine microorganisms, like fungi, are a rich source of novel bioactive compounds with potential therapeutic applications.
  • Dual Action: Neuroprotection and Anti-inflammation: TMC-256C1 exhibits a desirable dual action, simultaneously protecting neurons from oxidative damage and dampening inflammatory responses in the brain. This is particularly significant as many neurodegenerative diseases involve both pathologies.
  • The Central Role of HO-1: The research strongly suggests that the beneficial effects of TMC-256C1 are largely mediated by its ability to upregulate Heme Oxygenase-1 (HO-1). HO-1 is a critical endogenous antioxidant and anti-inflammatory enzyme, making it a prime target for therapeutic intervention.
  • Nrf2 as the Key Regulator: The study identifies Nuclear factor-erythroid 2-related factor 2 (Nrf2) as the crucial transcription factor that TMC-256C1 activates to induce HO-1 expression. Nrf2 is a master regulator of cellular defense against oxidative stress.
  • Signaling Pathway Activation: TMC-256C1 appears to activate HO-1 and Nrf2 through the p38 MAPK and PI3K/Akt signaling pathways. Understanding these upstream pathways provides valuable insights into the compound's mechanism of action.
  • Inhibition of NF-κB: In the context of neuroinflammation, TMC-256C1 effectively suppresses the activation of NF-κB, a central transcription factor in inflammatory signaling, by preventing the degradation of its inhibitor, IκB-α.

Key Results

  • Cytoprotective Effects: TMC-256C1 protected HT22 cells from glutamate-induced cytotoxicity and significantly reduced glutamate-induced ROS generation in a dose-dependent manner.
  • Anti-inflammatory Effects: In LPS-stimulated BV2 cells, TMC-256C1 significantly decreased the mRNA expression of pro-inflammatory cytokines TNF-α, IL-6, and IL-12. It also suppressed NO and PGE2 production by reducing iNOS and COX-2 protein expression.
  • HO-1 Induction: TMC-256C1 dose-dependently increased HO-1 protein expression in both HT22 and BV2 cells.
  • Nrf2 Activation: TMC-256C1 promoted the nuclear translocation of Nrf2 in both cell types, and Nrf2 siRNA blocked HO-1 induction.
  • MAPK and PI3K/Akt Activation: TMC-256C1 activated the p38 MAPK and PI3K/Akt pathways, and inhibition of p38 MAPK or PI3K/Akt pathways attenuated HO-1 induction.
  • HO-1 Dependency: Inhibition of HO-1 with SnPP reversed the cytoprotective effects of TMC-256C1 in HT22 cells and partially reversed its anti-inflammatory effects in BV2 cells.

Limitations and Future Work

  • In vivo Studies: The study was conducted using in vitro cell models. Future work should involve in vivo studies in animal models of neurodegenerative diseases to confirm these findings and assess the therapeutic potential of TMC-256C1 in a more complex biological system.
  • Pharmacokinetics and Toxicology: Comprehensive pharmacokinetic and toxicological studies would be necessary to evaluate the safety and efficacy of TMC-256C1 for potential drug development.
  • Further Mechanistic Elucidation: While key pathways have been identified, further research could explore other potential targets or interactions of TMC-256C1.
  • Structure-Activity Relationship: Investigating the structure-activity relationship of TMC-256C1 and its analogs could lead to the development of more potent or selective compounds.

Summary updated

Abstract

In the course of searching for bioactive secondary metabolites from marine fungi, TMC-256C1 was isolated from an ethyl acetate extract of the marine-derived fungus Aspergillus sp. SF6354. TMC-256C1 displayed anti-neuroinflammatory effect in BV2 microglial cells induced by lipopolysaccharides (LPS) as well as neuroprotective effect against glutamate-stimulated neurotoxicity in mouse hippocampal HT22 cells. TMC-256C1 was shown to develop a cellular resistance to oxidative damage caused by glutamate-induced cytotoxicity and reactive oxygen species (ROS) generation in HT22 cells, and suppress the inflammation process in LPS-stimulated BV2 cells. Furthermore, the neuroprotective and anti-neuroinflammatory activities of TMC-256C1 were associated with upregulated expression of heme oxygenase (HO)-1 and nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2) in HT22 and BV2 cells. We also found that TMC-256C1 activated p38 mitogen-activated protein kinases (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathways in HT22 and BV2 cells. These results demonstrated that TMC-256C1 activates HO-1 protein expression, probably by increasing nuclear Nrf2 levels via the activation of the p38 MAPK and PI3K/Akt pathways.
BibTeX
@article{kim2016anti,
  author = {Dongcheol Kim and Kwang Ho Cho and Wonmin Ko and Chi‐Su Yoon and Jae Ho Sohn and Joung Han Yim and Youn‐Chul Kim and Hyuncheol Oh},
  title = {{Anti-Inflammatory and Cytoprotective Effects of TMC-256C1 from Marine-Derived Fungus Aspergillus sp. SF-6354 via up-Regulation of Heme Oxygenase-1 in Murine Hippocampal and Microglial Cell Lines}},
  journal = {International Journal of Molecular Sciences},
  year = {2016},
  doi = {10.3390/ijms17040529},
}
Figure